Head of Global Cybersecurity at Legend Biotech

Franklin Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Senior leadership experience in cybersecurity, capable of providing high-level strategic direction and hands-on implementation
Expertise in developing and implementing cybersecurity capabilities across global operations
Ability to report to the Head of Information Technology and serve as a member of the Global IT Leadership Team
Authority to make decisions on technical direction, methodologies, approaches, processes, project execution (timelines, milestones, resource allocation within budget)
Need for higher-level approvals on significant budget allocations, strategic shifts, or major actions

Responsibilities

Lead the creation of a comprehensive cybersecurity strategy aligned with global business objectives; develop policies to protect information assets and ensure regulatory compliance; balance security with operational efficiency via a risk-based approach
Identify, assess, and mitigate cybersecurity risks across all regions and systems; develop and apply risk management frameworks; perform regular threat assessments to address vulnerabilities proactively
Establish and maintain robust incident response protocols, including detection, response, and recovery procedures; lead the organization through high-stakes incidents, minimizing operational impact and safeguarding data integrity
Develop and implement cybersecurity solutions tailored to specific risk profiles; use a risk-based approach to prioritize critical vulnerabilities; allocate resources efficiently; continuously monitor and adapt solutions to evolving threats
Collaborate with the Global IT Leadership Team to align IT and cybersecurity initiatives; report on cybersecurity performance, risk status, and incidents to executive stakeholders and the audit committee
Oversee the global cybersecurity team, including recruitment, training, and development; promote a culture of security awareness and ensure alignment with cybersecurity goals
Select, implement, and oversee cybersecurity technologies and solutions; manage third-party vendor relationships to ensure compliance with organizational cybersecurity standards

Skills

Cybersecurity Strategy

Risk Management

Threat Analysis

Policy Development

Regulatory Compliance

GRC

IT Leadership

Global Security Operations

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free